Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Aug 27, 2013; 5(8): 439-444
Published online Aug 27, 2013. doi: 10.4254/wjh.v5.i8.439
Published online Aug 27, 2013. doi: 10.4254/wjh.v5.i8.439
Variable | Control (n = 43) | Hepatitis B patients (n = 89) | P value |
Gender (female/male) | 31 (72.1)/12 (27.9) | 39 (43.8)/50 (56.2) | 0.004 |
Age (yr) | 35.4 ± 12.64 | 41.5 ±1 3.02 | 0.012 |
Platelet count (103μL) | 272.0 (242-342) | 179.0 (147-231) | < 0.001 |
Total bilirubin (mg/dL) | 0.6 (0.4-0.8) | 0.8 (0.6-1) | 0.009 |
AST (IU/L) | 17.0 (14-20) | 45.0 (30-68) | < 0.001 |
ALT (IU/L) | 16.0 (11-19) | 56.0 (36-111) | < 0.001 |
AP (IU/L) | 69.0 (53-79) | 72.0 (61-90) | 0.086 |
GGT (IU/L) | 17.0 (14-27) | 29.0 (21-50) | < 0.001 |
Neutrophil count | 4.3 (3.4-4.9) | 3.4 (2.9-4.7) | 0.004 |
Lymphocyte count | 2.1 (1.6-2.4) | 2.0 (1.6-2.4) | 0.355 |
N/L | 2.1 (1.5-2.8) | 1.9 (1.4-2.3) | 0.123 |
APRI score | 0.1 (0.1-0.1) | 0.6 (0.3-1.1) | < 0.001 |
- Citation: Celikbilek M, Dogan S, Gursoy S, Zararsız G, Yurci A, Ozbakır O, Guven K, Yucesoy M. Noninvasive assessment of liver damage in chronic hepatitis B. World J Hepatol 2013; 5(8): 439-444
- URL: https://www.wjgnet.com/1948-5182/full/v5/i8/439.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i8.439